219 related articles for article (PubMed ID: 21153910)
1. The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation.
Rodríguez-Muñoz M; Sánchez-Blázquez P; Vicente-Sánchez A; Bailón C; Martín-Aznar B; Garzón J
Cell Mol Life Sci; 2011 Sep; 68(17):2933-49. PubMed ID: 21153910
[TBL] [Abstract][Full Text] [Related]
2. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Wang JB; Garzón J
Cell Signal; 2008 Oct; 20(10):1855-64. PubMed ID: 18652891
[TBL] [Abstract][Full Text] [Related]
3. RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the N-methyl-D-aspartate receptor-calmodulin-dependent protein kinase II pathway.
Garzón J; Rodríguez-Muñoz M; Vicente-Sánchez A; Bailón C; Martínez-Murillo R; Sánchez-Blázquez P
Antioxid Redox Signal; 2011 Aug; 15(4):873-87. PubMed ID: 21348811
[TBL] [Abstract][Full Text] [Related]
4. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
[TBL] [Abstract][Full Text] [Related]
5. NO-released zinc supports the simultaneous binding of Raf-1 and PKCγ cysteine-rich domains to HINT1 protein at the mu-opioid receptor.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Antioxid Redox Signal; 2011 Jun; 14(12):2413-25. PubMed ID: 21235400
[TBL] [Abstract][Full Text] [Related]
6. The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.
Rodríguez-Muñoz M; Sánchez-Blázquez P; Vicente-Sánchez A; Berrocoso E; Garzón J
Neuropsychopharmacology; 2012 Jan; 37(2):338-49. PubMed ID: 21814188
[TBL] [Abstract][Full Text] [Related]
7. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
PLoS One; 2010 Jun; 5(6):e11278. PubMed ID: 20585660
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HINT1 Modulates Spinal Nociception and NMDA Evoked Behavior in Mice.
Shah RM; Peterson C; Strom A; Dillenburg M; Finzel B; Kitto KF; Fairbanks C; Wilcox G; Wagner CR
ACS Chem Neurosci; 2019 Oct; 10(10):4385-4393. PubMed ID: 31503445
[TBL] [Abstract][Full Text] [Related]
9. Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Curr Drug Abuse Rev; 2012 Sep; 5(3):199-226. PubMed ID: 22920535
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling.
Rodríguez-Muñoz M; Garzón J
Mol Neurobiol; 2013 Dec; 48(3):769-82. PubMed ID: 23666425
[TBL] [Abstract][Full Text] [Related]
11. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J
Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699
[TBL] [Abstract][Full Text] [Related]
12. HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.
Vicente-Sánchez A; Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
Mol Brain; 2013 Oct; 6():42. PubMed ID: 24093505
[TBL] [Abstract][Full Text] [Related]
13. HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia.
Garzón J; Herrero-Labrador R; Rodríguez-Muñoz M; Shah R; Vicente-Sánchez A; Wagner CR; Sánchez-Blázquez P
Neuropharmacology; 2015 Feb; 89():412-23. PubMed ID: 25445489
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Vicente-Sánchez A; Garzón J
Antioxid Redox Signal; 2013 Nov; 19(15):1766-82. PubMed ID: 23600761
[TBL] [Abstract][Full Text] [Related]
15. The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders.
Rodríguez-Muñoz M; Cortés-Montero E; Pozo-Rodrigálvarez A; Sánchez-Blázquez P; Garzón-Niño J
Oncotarget; 2015 Nov; 6(34):35458-77. PubMed ID: 26461475
[TBL] [Abstract][Full Text] [Related]
16. Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.
Garzón-Niño J; Rodríguez-Muñoz M; Cortés-Montero E; Sánchez-Blázquez P
Sci Rep; 2017 Feb; 7():43468. PubMed ID: 28240305
[TBL] [Abstract][Full Text] [Related]
17. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
18. Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery?
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Curr Drug Abuse Rev; 2008 Jun; 1(2):222-38. PubMed ID: 19630721
[TBL] [Abstract][Full Text] [Related]
19. Magnesium and Morphine in the Treatment of Chronic Neuropathic Pain-A Biomedical Mechanism of Action.
Kulik K; Żyżyńska-Granica B; Kowalczyk A; Kurowski P; Gajewska M; Bujalska-Zadrożny M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948397
[TBL] [Abstract][Full Text] [Related]
20. Brain-specific Galphaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway.
Sánchez-Blázquez P; Rodríguez-Muñoz M; de la Torre-Madrid E; Garzón J
Cell Signal; 2009 Sep; 21(9):1444-54. PubMed ID: 19446022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
